Skip to Main Content

Author Details

Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1992
75
37
PMIDPaper TitleJournal TitlePublished Year
37770128Immunosuppressive CD29<sup>+</sup> Treg accumulation in the liver in mice on checkpoint inhibitor therapy.Gut2024
37081117Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity.Nat Rev Cancer2023
37595566Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.Cell2023
37624046CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18.J Immunol2023
37726418Biomarkers for immunotherapy of hepatocellular carcinoma.Nat Rev Clin Oncol2023
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
35833139Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma.Front Immunol2022
35366023Innate lymphoid cells at the crossroads of innate and adaptive immunity.Hepatology2022
35663967Plasticity of Innate Lymphoid Cells in Cancer.Front Immunol2022
36055226Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD.Cancer Cell2022
33323397Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma.Cancer Discov2021
35121970Microbiome genomics for cancer prediction.Nat Cancer2020
30688989The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.Cancer Immunol Immunother2019
30738077Combined locoregional-immunotherapy for liver cancer.J Hepatol2019
30578687Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer.Hepatology2019
30414862Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.J Hepatol2019
29066575CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC.Gut2018
29959458Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.Cancer Immunol Immunother2018
29602801Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients.Clin Cancer Res2018
29798856Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells.Science2018
27803114Shall we blame CD4 T cells for everything?Gut2017
28331613Systematic evaluation of immune regulation and modulation.J Immunother Cancer2017
27816492Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.J Hepatol2017
25274062Immunogenicity of necrotic cell death.Cell Mol Life Sci2015
25616156Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.Eur J Immunol2015
25666193Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.Gut2015
25637366Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage.Cancer Immunol Res2015
24954163Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC.Hepatology2014
25401795Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage.PLoS One2014
24810636IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.Eur J Immunol2014
23796475Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.J Hepatol2013
24216478Peptidases released by necrotic cells control CD8+ T cell cross-priming.J Clin Invest2013
24030702Hepatocellular carcinoma from an immunologic perspective.Clin Cancer Res2013
22304731S100A9 a new marker for monocytic human myeloid-derived suppressor cells.Immunology2012
23170250Primary sterile necrotic cells fail to cross-prime CD8(+) T cells.Oncoimmunology2012
23243621Human Th17 cells in patients with cancer: Friends or foe?Oncoimmunology2012
23017136Immune suppression: the hallmark of myeloid derived suppressor cells.Immunol Invest2012
23108303Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma.Dig Dis2012
23077247Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.J Leukoc Biol2012
22615204Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses.J Immunol2012
21237299Myeloid derived suppressor cells in human diseases.Int Immunopharmacol2011
21493801Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.Blood2011
20139774Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.J Immunother2010
20921533Differential suppression of tumor-specific CD8+ T cells by regulatory T cells.J Immunol2010
20511546Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells.J Immunol2010
20478057A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma.BMC Cancer2010
20528121Immunotherapy of hepatocellular carcinoma.Expert Rev Gastroenterol Hepatol2010
20460904Immune responses in hepatocellular carcinoma.Dig Dis2010
20525890CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.J Immunol2010
20619917Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction?J Hepatol2010
  • 1 - 50 of 75

Recommended Authors

Tiago da Silva Medina
International Research Center, A.C.Camargo Cancer Center
Career Start Year 2016
Number of shared co-authors 0
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
Dipti Vijayan
QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 1
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Lili Yang
University of California Los Angeles
Career Start Year 2009
Number of shared co-authors 0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 0
Tori N Yamamoto
National Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 0
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 7
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 4
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 4
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 3
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Career Start Year 1985
Number of shared co-authors 6
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 4
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year 1978
Number of shared co-authors 6
Steven A Rosenberg
University of Colorado School of Medicine
Career Start Year 1961
Number of shared co-authors 9

Collaborators

Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 66
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 13
Bernd Heinrich
Clinic for Gastroenterology, Hannover Medical School
Co-authored papers 11
Qianfei Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
Co-authored papers 6
Qiong Fu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
David Agdashian
university of california san diego, 9452 Medical Center Drive
Co-authored papers 5
Milan Sandhu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Alexander Kroemer
Co-authored papers 4
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Mathuros Ruchirawat
Chulabhorn Research Institute
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Co-authored papers 3
Drew Pratt
Co-authored papers 2
Vishal Thovarai
Center for Cancer Research
Co-authored papers 2
Miaojun Han
Department of Research and Development, Shanghai United Imaging Intelligence Co.
Co-authored papers 2
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Eytan Ruppin
National Cancer Institute
Co-authored papers 2
Soumen Roy
Center for Cancer Research
Co-authored papers 2
Thomas Ritz
Southern Methodist University
Co-authored papers 2
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 2
Masaki Terabe
National Cancer Institute
Co-authored papers 2
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Bernd Schnabl
University of California San Diego
Co-authored papers 1
Casey M Theriot
College of Veterinary Medicine, North Carolina State University
Co-authored papers 1
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Eran Elinav
German Cancer Research Center
Co-authored papers 1
Release 1.2